These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7051796)

  • 1. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
    Franciosa JA; Weber KT; Levine TB; Kinasewitz GT; Janicki JS; West J; Henis MM; Cohn JN
    Am Heart J; 1982 Sep; 104(3):587-94. PubMed ID: 7051796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial.
    Franciosa JA; Jordan RA; Wilen MM; Leddy CL
    Circulation; 1984 Jul; 70(1):63-8. PubMed ID: 6373050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study.
    Conradson TB; Rydén L; Ahlmark G; Saetre H; Persson S; Nyquist O; Wernersson B
    Am Heart J; 1984 Oct; 108(4 Pt 1):1001-6. PubMed ID: 6385678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prazosin vs placebo on chronic left ventricular heart failure.
    Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D
    Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure.
    Reifart N; Kaltenbach M; Bussmann WD
    Eur Heart J; 1984 Jul; 5(7):568-80. PubMed ID: 6479183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure.
    Aronow WS; Greenfield RS; Alimadadian H; Danahy DT
    Am J Cardiol; 1977 Nov; 40(5):789-93. PubMed ID: 335867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation.
    Kleaveland JP; Reichek N; McCarthy DM; Chandler T; Priest C; Muhammed A; Makler PT; Hirshfeld J
    Am J Cardiol; 1986 May; 57(13):1109-16. PubMed ID: 3518384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
    Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
    Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
    J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM; Brooks NH; Lawrence GP; Testa HJ; Ward C
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hydralazine therapy for chronic refractory heart failure.
    Chatterjee K; Parmley WW; Massie B; Greenberg B; Werner J; Klausner S; Norman A
    Circulation; 1976 Dec; 54(6):879-83. PubMed ID: 825327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and short-term effects of clonidine in heart failure.
    Giles TD; Thomas MG; Quiroz A; Rice JC; Plauche W; Sander GE
    Angiology; 1987 Jul; 38(7):537-48. PubMed ID: 3304028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with hydralazine in mild to moderate mitral or aortic incompetence.
    Jensen T; Kornerup HJ; Lederballe O; Videbaek J; Henningsen P
    Eur Heart J; 1983 May; 4(5):306-12. PubMed ID: 6617676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.